logo-biolife.png
BIOLIFE4D Announces Intention to Submit Draft Registration Statement for Underwritten Public Offering of Common Stock
December 31, 2021 09:15 ET | BIOLIFE4D
BUFFALO GROVE, Ill., Dec. 31, 2021 (GLOBE NEWSWIRE) -- BIOLIFE4D Corporation today announced that it intends to submit a draft registration statement on Form S-1 with the U.S. Securities and...
Reports and Data.jpeg-01
Cardiac surgery instruments Market To Reach USD 2.06 Billion By 2027 | Reports And Data
January 28, 2020 10:00 ET | Reports and Data
New York, Jan. 28, 2020 (GLOBE NEWSWIRE) -- The Global Cardiac Surgery Instruments Market is forecast to reach USD 2.06 Billion by 2027, according to a new report by Reports and Data. Cardiac...
logo-biolife.png
BIOLIFE4D Modifies its Regulation A+ (Mini-IPO) Offering Following Significant Scientific Achievement
September 16, 2019 08:00 ET | BIOLIFE4D
Company surpasses $3M in accepted investments CHICAGO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for...
logo-biolife.png
BIOLIFE4D Launches Second Regulation A+ (Mini-IPO) Offering Due to Popular Demand
September 06, 2019 07:30 ET | BIOLIFE4D
CHICAGO, Sept. 06, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched its...
Picture1.png
BIOLIFE4D Appoints Management Advisory Board
January 28, 2019 08:30 ET | BIOLIFE4D Corporation
CHICAGO, Jan. 28, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has established a...
Picture1.png
BIOLIFE4D Successfully Demonstrates Ability to 3D Bioprint Human Cardiac Tissue
June 25, 2018 08:00 ET | BIOLIFE4D Corporation
CHICAGO, June 25, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully...
Picture1.png
BIOLIFE4D Modifies its Regulation A+ (Mini-IPO) Offering Due to Popular Demand
June 23, 2018 08:00 ET | BIOLIFE4D Corporation
CHICAGO, June 23, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it will be modifying...
Picture1.png
BIOLIFE4D Establishes Operations in Houston as Part of Commercialization Strategy for Life-Saving 3D Bioprinting Technology
May 29, 2018 08:02 ET | BIOLIFE4D Corporation
CHICAGO, May 29, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it is now a resident...
Technology and Pathways Advancing Future Transplant Patient Care Discussed at the International Society for Heart and Lung Transplantation (ISHLT) 38th Annual Meeting & Scientific Sessions NICE, FR, April 13, 2018 (GLOBE NEWSWIRE) -- During the International Society for Heart and Lung Transplantation (ISHLT) 38th Annual Meeting & Scientific Sessions, an entire symposium was...
Picture1.png
BIOLIFE4D Signs Laboratory Service Agreement with Northwestern University
February 05, 2018 08:01 ET | BIOLIFE4D Corporation
CHICAGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has signed a...